Inspire Medical Systems Securities Lawsuit
Analysis based on 15 articles · First reported Nov 17, 2025 · Last updated Dec 12, 2025
The market is negatively impacted by the alleged securities fraud by Inspire Medical Systems, leading to a significant drop in its stock price and a dramatic reduction in its earnings guidance. This event highlights the risks associated with product launches and corporate transparency, potentially increasing investor scrutiny on similar companies.
Inspire Medical Systems is facing a securities class action lawsuit filed by Hagens Berman, alleging the company misled investors about the launch of its Inspire V device for obstructive sleep apnea. The lawsuit claims Inspire Medical Systems concealed critical operational failures, including delays in Medicare claims processing software updates and a surplus of the older Inspire IV device, which hindered demand for the new product. These undisclosed issues led Inspire Medical Systems to slash its 2025 earnings guidance by over 80% and caused its stock price to decline by more than 32% on August 4, 2025. Reed Kathrein of Hagens Berman is leading the investigation, focusing on the alleged concealment of these critical points. The lawsuit is pending in the United States — United States District Court for the District of Minnesota, with a Lead Plaintiff Deadline of January 5, 2026.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard